• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Confidentiality in a Time of COVID

Confidentiality in a Time of COVID

September 3, 2020
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

There are two sets of laws governing the release of substance abuse information. One requires the patient’s signature for all disclosures, while the other takes a more liberal approach.


The liberal branch is the Health Insurance Portability and Accountability Act (HIPAA), which allows disclosures without the patient’s consent to “covered entities” (eg, doctors, therapists, pharmacists, and insurers who are paying for the patient’s care). The Substance Abuse and Mental Health Services Administration (SAMHSA) has a different take on confidentiality, requiring signed consent before disclosures related to substance use disorders. Most, but not all, psychiatric providers fall under SAMHSA’s umbrella.


Does SAMHSA Govern Your Practice?
SAMHSA law applies to group and individual practices that meet #1 and #2:



  1. “Holds itself out” (eg, advertises) as providing treatment or referrals for alcohol or drug abuse

  2. Is certified by the federal government or receives federal support, including any of the following:

    • Uses a DEA license to prescribe controlled substances for the treatment of substance use disorders

    • Receives any federal funding, including Medicare payments, even if the funding is unrelated to the treatment of substance use disorders

    • Is granted tax exempt status by the IRS




On July 13, 2020, SAMHSA modernized the law to allow disclosure without patient consent during emergencies that result from a natural disaster. COVID-19 is included alongside hurricanes and floods in the list, though the opioid crisis is not. Further updates to the law are planned for 2021.

General Psychiatry
    www.thecarlatreport.com
    Issue Date: September 3, 2020
    SUBSCRIBE NOW
    Table Of Contents
    CME Post-Test - When to Use Lithium, TCPR, September 2020
    Highlights From This Issue
    How COVID-19 Affects the Brain
    Who Should Get Lithium?
    Modern Challenges of Delusional Disorder
    Two Augmentation Strategies Compared in Bipolar I
    Confidentiality in a Time of COVID
    DOWNLOAD NOW
    Featured Book
    • MFB6eCover.jpg

      Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

      Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
      READ MORE
    Featured Video
    • therapist_canstockphoto9201097.jpg
      General Psychiatry

      Using SAMe In Clinical Practice with Garrett Rossi, MD

      Read More
    Featured Podcast
    • canstockphoto22709844.jpg
      General Psychiatry

      Psychopharm Commandment #10: Don’t Fear these Meds

      Surprising health benefits of our riskiest meds: Lithium, quetiapine, and clozapine.

      Listen now
    Recommended
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report

    Contact

    info@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.